Psoriatic Arthritis

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
Kurt de Vlam, Alexis Ogdie, Andrew G Bushmakin, Joseph C Cappelleri, Roy Fleischmann, Peter C Taylor, Valderilio Azevedo, Lara Fallon, John Woolcott, Philip J Mease

RMD Open Jul 2021, 7 (2) e001609; DOI: 10.1136/rmdopen-2021-001609
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study
Veerle Stouten, Sofia Pazmino, P Verschueren, Pavlos Mamouris, René Westhovens, Kurt de Vlam, Delphine Bertrand, Kristien Van der Elst, Bert Vaes, Diederik De Cock

RMD Open Jun 2021, 7 (2) e001671; DOI: 10.1136/rmdopen-2021-001671
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden
Anton Jonatan Landgren, Mats Dehlin, Lennart Jacobsson, Ulrika Bergsten, Eva Klingberg

RMD Open May 2021, 7 (2) e001568; DOI: 10.1136/rmdopen-2021-001568
The frequency of uveitis in patients with adult versus childhood spondyloarthritis
Matthew Turk, Jacqueline Hayworth, Tatiana Nevskaya, Janet Pope

RMD Open Aug 2020, 6 (2) e001196; DOI: 10.1136/rmdopen-2020-001196
Does socioeconomic status make a difference? A register-based study on the extent to which cardiovascular screening in patients with inflammatory arthritis leads to recommended follow-up in general practice
Anette Hvenegaard Kjeldgaard, Kim Hørslev-Petersen, Sonja Wehberg, Jens Soendergaard, Jette Primdahl

RMD Open Aug 2020, 6 (2) e000940; DOI: 10.1136/rmdopen-2019-000940
Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis
Hannah den Braanker, Kim Wervers, Adriana M C Mus, Priyanka S Bangoer, Nadine Davelaar, Jolanda Luime, Ilja Tchetverikov, J M W Hazes, Marijn Vis, Erik Lubberts, Marc R Kok

RMD Open Jul 2020, 6 (2) e001175; DOI: 10.1136/rmdopen-2020-001175
Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
Mark Kacar, John Fitton, Andrew K Gough, Maya H Buch, Dennis G McGonagle, Sinisa Savic

RMD Open Jul 2020, 6 (2) e001246; DOI: 10.1136/rmdopen-2020-001246
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study
Philip J Mease, Dafna D Gladman, Atul Deodhar, Dennis G McGonagle, Peter Nash, Wolf-Henning Boehncke, Alice Gottlieb, Xie L Xu, Stephen Xu, Elizabeth C Hsia, Chetan S Karyekar, Philip S Helliwell

RMD Open Jul 2020, 6 (2) e001217; DOI: 10.1136/rmdopen-2020-001217
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study
P G Conaghan, Rieke Alten, Atul Deodhar, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl, Vibeke Strand

RMD Open Jun 2020, 6 (2) e001240; DOI: 10.1136/rmdopen-2020-001240
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
Glenn Haugeberg, Brigitte Michelsen, Arthur Kavanaugh

RMD Open May 2020, 6 (1) e001223; DOI: 10.1136/rmdopen-2020-001223

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages